United Allergy Services (UAS) is a Health Care startup, established in 2009 in the United States, that focuses on improving the quality of life for patients suffering from allergies. With the slogan "Proudly helping primary care providers across the country make allergy testing and immunotherapy convenient to patients," UAS aims to advance the understanding of immunotherapy as the only known disease-modifying treatment for allergies. UAS works with more than 2,450 practitioners across 20 states and has already helped more than 350,000 patients break free from their symptoms. The company's innovative approach revolves around empowering primary care providers and other specialists to provide safe, effective, and customized allergy treatment throughout the United States. UAS Clinical Allergy Technicians/Specialists (CAT/CAS) play a crucial role by working under the provider's direct supervision to test, analyze, and perform dilutions for immunotherapy treatments. The company's collaboration with primary care providers not only expands its reach but also educates and provides patients with customized treatment programs using UAS's proprietary protocol. Moreover, the last investment of UAS was a substantial $5.00M Venture Round investment on 26 April 2013. However, the specific investors for this round are not provided. In conclusion, United Allergy Services has shown significant progress since its founding year, with a strong focus on providing innovative allergy treatments and expanding its reach across the United States. Their dedication to transforming allergy care in America positions the company as an aspirational opportunity for potential investors and job seekers in the healthcare industry. For more details, interested parties can visit their website at www.unitedallergyservices.com.
No recent news or press coverage available for United Allergy Services.